Aveanna Healthcare Holdings, Inc. (AVAH) stock
Close on Oct 30, 2026Market cap $2.87BP/E 10.7Yield –
Earnings
Aveanna Healthcare's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Aveanna Healthcare's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 27, 2026 | Nov 5, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jul 4, 2026 | Aug 13, 2026before the open | $670.50M | +13.7% | $0.18 | $0.22 | Release |
| Q1 FY2026ended Apr 4, 2026 | May 14, 2026before the open | $647.90M | +15.9% | $0.19 | $0.18 | Release |
| Q4 FY2025ended Jan 3, 2026 | Mar 19, 2026before the open | $662.50M | +27.4% | $0.80 | $0.17 | Release |
| Q3 FY2025ended Sep 27, 2025 | Nov 6, 2025before the open | $621.90M | +22.2% | $0.06 | $0.15 | Release |
| Q2 FY2025ended Jun 28, 2025 | Aug 7, 2025before the open | $589.60M | +16.8% | $0.13 | $0.18 | Release |
| Q1 FY2025ended Mar 29, 2025 | May 8, 2025before the open | $559.20M | +14.0% | $0.03 | $0.10 | Release |
| Q4 FY2024ended Dec 28, 2024 | Mar 13, 2025before the open | $519.90M | +8.6% | $0.14 | $0.05 | Release |
| Q3 FY2024ended Sep 28, 2024 | Nov 7, 2024before the open | $509.00M | +6.5% | -$0.22 | $0.02 | Release |
| Q2 FY2024ended Jun 29, 2024 | Aug 8, 2024before the open | $505.00M | – | $0.07 | $0.01 | Release |
| Q1 FY2024ended Mar 30, 2024 | May 9, 2024before the open | $490.70M | +5.2% | -$0.06 | -$0.03 | Release |
| Q4 FY2023ended Dec 30, 2023 | Mar 14, 2024before the open | $478.80M | +6.1% | -$0.13 | -$0.02 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023before the open | $478.00M | +7.9% | -$0.54 | -$0.03 | Release |
| Q1 FY2023ended Apr 1, 2023 | May 11, 2023before the open | $466.40M | +3.5% | -$0.17 | -$0.05 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 16, 2023before the open | $451.10M | +8.9% | -$1.28 | -$0.03 | Release |
| Q3 FY2022ended Oct 1, 2022 | Nov 9, 2022after the close | $443.00M | +7.7% | $0.13 | -$0.03 | Release |
| Q2 FY2022ended Jul 2, 2022 | Aug 11, 2022after the close | $443.00M | – | -$2.56 | $0.03 | Release |
| Q1 FY2022ended Apr 2, 2022 | May 11, 2022after the close | $450.50M | – | $0.14 | $0.04 | Release |
| Q4 FY2021ended Jan 1, 2022 | Mar 28, 2022after the close | $414.10M | – | -$0.68 | $0.10 | Release |
| Q3 FY2021ended Oct 2, 2021 | Nov 15, 2021after the close | $411.30M | – | $0.01 | $0.11 | Release |
| Q2 FY2021ended Jul 3, 2021 | Aug 11, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Apr 3, 2021 | May 25, 2021after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Aveanna Healthcare's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | FY2026 | $2.68B | – | New | Aug 13, 2026 |
| Revenue | FY2026 | $2.56B – $2.58B | $2.54B – $2.56B | Raised | May 14, 2026 |
| RevenueGAAP | FY2026 | $2.54B – $2.56B | – | New | Mar 19, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $365.00M | $328.00M – $332.00M | Raised | Aug 13, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $318.00M – $322.00M | – | New | Mar 19, 2026 |
Guidance vs results
The last range Aveanna Healthcare gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $2.43B – $2.45B | $2.43BΣ4Q | Within range |
Guidance history
Every forecast Aveanna Healthcare put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 13, 2026 | Adjusted EBITDA | FY2026 | $365.00M | Raised |
| Aug 13, 2026 | Revenue | FY2026 | $2.68B | New |
| May 14, 2026 | Adjusted EBITDA | FY2026 | $328.00M – $332.00M | Raised |
| May 14, 2026 | Revenue | FY2026 | $2.56B – $2.58B | Raised |
| Mar 19, 2026 | Adjusted EBITDA | FY2026 | $318.00M – $322.00M | New |
| Mar 19, 2026 | Revenue | FY2026 | $2.54B – $2.56B | New |
| Jan 14, 2026 | Adjusted EBITDA | FY2025 | $318.00M – $322.00M | New |
| Jan 14, 2026 | Normalized Adjusted EBITDA | FY2025 | $298.00M – $302.00M | Lowered |
| Jan 14, 2026 | Adjusted EBITDA | FY2026 | $318.00M – $322.00M | New |
| Jan 14, 2026 | Net income | FY2025 | $181.00M – $220.00M | New |
| Jan 14, 2026 | Revenue | FY2025 | $2.43B – $2.45B | New |
| Jan 14, 2026 | Revenue | FY2026 | $2.54B – $2.56B | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $300.00M | Raised |
| Nov 6, 2025 | revenue | FY2025 | $2.38B | New |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $270.00M | Raised |
| Aug 7, 2025 | Revenue | FY2025 | $2.30B | Raised |
| May 8, 2025 | Adjusted EBITDA | FY2025 | $207.00M | Raised |
| May 8, 2025 | Revenue | FY2025 | $2.15B | Raised |
| Mar 13, 2025 | Adjusted EBITDA | FY2025 | $190.00M – $194.00M | New |
| Mar 13, 2025 | Revenue | FY2025 | $2.10B – $2.12B | New |
| Nov 7, 2024 | Adjusted EBITDA | FY2024 | $168.00M | Raised |
| Nov 7, 2024 | Revenue | FY2024 | $2.00B | New |
| Aug 8, 2024 | Adjusted EBITDA | FY2024 | $158.00M | Raised |
| Aug 8, 2024 | Revenue | FY2024 | $1.99B | Raised |
| May 9, 2024 | Adjusted EBITDA | FY2024 | $150.00M | Raised |
| May 9, 2024 | Revenue | FY2024 | $1.97B | Narrowed |
| Mar 14, 2024 | Adjusted EBITDA | FY2024 | $146.00M – $150.00M | New |
| Mar 14, 2024 | Revenue | FY2024 | $1.96B – $1.98B | New |
| Nov 9, 2023 | Adjusted EBITDA | FY2023 | $134.00M – $137.00M | Raised |
| Nov 9, 2023 | revenue | FY2023 | $1.87B – $1.88B | Raised |
| May 11, 2023 | Adjusted EBITDA | FY2023 | $130.00M | Reaffirmed |
| May 11, 2023 | Revenue | FY2023 | $1.84B | Reaffirmed |
| Mar 16, 2023 | Adjusted EBITDA | FY2023 | $130.00M | New |
| Mar 16, 2023 | Revenue | FY2023 | $1.84B | New |
| Nov 9, 2022 | Adjusted EBITDA | FY2022 | $128.00M | Lowered |
| Nov 9, 2022 | Revenue | FY2022 | $1.78B | Lowered |
| Jul 19, 2022 | Adjusted EBITDA | FY2022 | $150.00M | Lowered |
| Jul 19, 2022 | Revenue | FY2022 | $1.79B | New |
| Mar 28, 2022 | Adjusted EBITDA | FY2022 | $190.00M – $205.00M | New |
| Mar 28, 2022 | Revenue | FY2022 | $1.89B – $1.92B | New |
| Nov 15, 2021 | Adjusted EBITDA | FY2021 | $185.00M | New |
| Nov 15, 2021 | Revenue | FY2021 | $1.68B – $1.68B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Aveanna Healthcare filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- News
- News
- Update
- Results
- Update
- Results
- News
- Results
- Results
- Update
- Results
- Results
- Update